SIST EN ISO 10993-12:2021 PDF

Overview

SIST EN ISO 10993-12:2021, titled Biological evaluation of medical devices - Part 12: Sample preparation and reference materials, is a harmonized European Standard published by CEN and ISO. This standard establishes essential requirements and guidance for the preparation of samples and the selection of reference materials for biological testing of medical devices, primarily under the framework of the ISO 10993 series. Its systematic procedures help ensure that test outcomes are meaningful and reproducible, supporting regulatory requirements such as the EU Medical Device Regulation (MDR 2017/745).

Focusing on the critical steps from sample selection to extract preparation, SIST EN ISO 10993-12:2021 serves as a foundation for valid biological evaluation, ultimately contributing to the overall safety and performance assessment of medical devices.

Key Topics

• Test Sample Selection: Guidance on choosing appropriate samples representative of the final medical device or its components, ensuring the biological evaluation is relevant to the end-use scenario.

• Preparation of Test Samples: Procedures for preparing samples to avoid contamination and ensure that additives, processing residues, and other critical factors are adequately considered.

• Selection of Representative Portions: Techniques to identify and include relevant parts of the device, such as coatings, adhesives, and joint areas, particularly when whole device testing is not feasible.

• Experimental Controls: Recommendations on the use of positive and negative controls, blanks, and certified reference materials (CRMs) to help interpret test system responses.

• Reference Materials: Requirements for the selection, certification, and use of reference materials critical for quality assurance and reproducibility between laboratories.

• Extract Preparation: Protocols for preparing device extracts using suitable solvents and containers, ensuring compatibility with biological test systems while simulating clinical use or exaggerating conditions, when necessary.

Applications

SIST EN ISO 10993-12:2021 is pivotal in various applications across the medical device industry, research, and regulatory landscapes:

• Biological Risk Assessment: Manufacturers use the standard to ensure biologically relevant, reproducible sample preparation in tests for cytotoxicity, sensitization, irritation, and other endpoints.

• Quality Control and Batch Release: Laboratories follow the standard to maintain consistency in the biological evaluation of multiple device lots, supporting robust quality systems.

• Regulatory Submissions: Compliance with SIST EN ISO 10993-12:2021 is often required for CE marking and international market access, as it aligns with MDR 2017/745 General Safety and Performance Requirements.

• Device Development and Material Change Management: R&D teams rely on the guidance when developing new devices or introducing new materials, ensuring ongoing compliance and safety validation.

• Comparative Testing and Interlaboratory Studies: The use of standardized sample preparation and reference materials enables direct comparison of results across different labs, which is critical for multicenter studies and regulatory reviews.

Related Standards

SIST EN ISO 10993-12:2021 should be used in conjunction with other ISO 10993 standards to ensure comprehensive biological evaluation of medical devices. Key related standards include:

• EN ISO 10993-1: Evaluation and testing within a risk management process - provides overarching principles for biological assessment.
• EN ISO 10993-5: Tests for in vitro cytotoxicity - focuses on cytotoxicity testing methods.
• EN ISO 10993-17: Establishment of allowable limits for leachable substances.
• EN ISO 10993-18: Chemical characterization of materials - details extraction for chemical analysis.
• ISO/TS 10993-19: Physico-chemical, morphological and topographical characterization of materials.

For device manufacturers and laboratories, adherence to SIST EN ISO 10993-12:2021 ensures that biological testing is robust, compliant, and produces reproducible data essential for device safety assessment and successful regulatory approval.

Keywords: biological evaluation of medical devices, sample preparation, reference materials, ISO 10993-12, medical device testing, MDR 2017/745, biological risk assessment, device extract preparation, experimental controls, quality assurance, regulatory compliance.